Formulation Development, Optimization by Box-Behnken Design, and In Vitro Characterization of Gefitinib Phospholipid Complex Based Nanoemulsion Drug Delivery System-Reference-Cited by-同舟云学术

Formulation Development, Optimization by Box-Behnken Design, and In Vitro Characterization of Gefitinib Phospholipid Complex Based Nanoemulsion Drug Delivery System

Published:2022-11-14 Issue: Volume: Page:
ISSN:1872-5120
Container-title:Journal of Pharmaceutical Innovation
language:en
Short-container-title:J Pharm Innov

Author:

Mohit ,Kumar Pankaj,Solanki Pavitra,Mangla Bharti,Aggarwal Geeta

Publisher

Springer Science and Business Media LLC

Subject

Drug Discovery,Pharmaceutical Science

Link

https://link.springer.com/content/pdf/10.1007/s12247-022-09690-6.pdf

Reference38 articles.

1. Alanazi WA, Alhamami HN, Alharbi M, et al. Angiotensin II type 1 receptor blockade attenuates gefitinib-induced cardiac hypertrophy via adjusting angiotensin II-mediated oxidative stress and JNK/P38 MAPK pathway in a rat model. Saudi Pharm J. 2022;30(8):1159–69. https://doi.org/10.1016/j.jsps.2022.06.020.

2. Butti R, Das S, Gunasekaran VP, et al. Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges. Mol Cancer. 2018;17(1):1–18. https://doi.org/10.1186/s12943-018-0797-x.

3. Sun H, Wu Y, Pan Z, et al. Gefitinib for epidermal growth factor receptor activated osteoarthritis subpopulation treatment. Biomedicine. 2018;32:223–33. https://doi.org/10.1016/j.ebiom.2018.06.002.

4. Godugu C, Doddapaneni R, Patel AR, et al. Novel gefitinib formulation with improved oral bioavailability in treatment of A431 skin carcinoma. Pharm Res. 2016;33(1):137–54. https://doi.org/10.1007/s11095-015-1771-6.

5. Van Erp NP, Gelderblom H, Guchelaar HJ. Clinical pharmacokinetics of tyrosine kinase inhibitors. Cancer Treat Rev. 2009;35(8):692–706. https://doi.org/10.1016/j.ctrv.2009.08.004.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral in vivo biodistribution of fluorescent labelled nano lipid carrier system of erlotinib using real time optical imaging technique;International Journal of Pharmaceutics;2024-10

2. Posaconazole-hemp seed oil loaded nanomicelles for invasive fungal disease;Scientific Reports;2024-07-18

3. Novel Phytosomal Formulation of Emblica officinalis Extracts with Its In Vivo Nootropic Potential in Rats: Optimization and Development by Box-Behnken Design;Journal of Chemistry;2024-04-04

4. Development of Erlotinib-Loaded Nanotransferosomal Gel for the Topical Treatment of Ductal Carcinoma in Situ;Nanomedicine;2024-04

5. Quality by Design Assisted Development of Luliconazole Transethosomes in Gel for the Management of Candida albicans Infection;ASSAY and Drug Development Technologies;2024-01-01